US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ASTRAZENECA PLC ADRhedged

53.28

0.0000

Volume:- -

Turnover:- -

Market Cap:1.60M

PE:- -

High:53.28

Open:53.28

Low:53.28

Close:53.28

52wk High:56.90

52wk Low:44.36

Shares:30.00K

Float Shares:10.00K

Volume Ratio:2.68

T/O Rate:- -

Dividend:0.58

Dividend Rate:1.08%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

AstraZeneca Rallies Friday, Outperforms Market

AstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors

Dizhe Pharma Surpasses 500 Million Yuan in First-Half Revenue, Seals Global Exclusive Licensing Pact with AstraZeneca for Sunvozertinib

Third Indication Approved in China for AstraZeneca's Ultomiris

AstraZeneca PLC Stock (AZN) Moved Up by 3.40% on Aug 19: What Signal Does It Send?

The Key to Pharma M&A: Never Shopping Hungry - Heard on the Street

BMO starts Exelixis at Market Perform into patent cliff

AstraZeneca Rises Tuesday, Outperforms Market

European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading

MT Newswires Live

AstraZeneca's Biologic Therapy Receives Dual Indication Approval for Launch in China

AstraZeneca to discontinue eVOLVE-Lung02 Phase III trial

Breakthrough: AstraZeneca and Daiichi Sankyo's ADC Shows Strong Efficacy in First-Line Lung Cancer Therapy

AstraZeneca (AZN) Gets a Buy from J.P. Morgan

AstraZeneca Discontinues Phase 3 Lung Cancer Trial for Volrustomig Combination

MT Newswires Live

AstraZeneca’s STEP Asthma Trial Completion: What It Could Mean for AZN Investors

New Approval in China for Enhertu, a Key Antibody-Drug Conjugate from Daiichi Sankyo and AstraZeneca

Cspc Innovation's Subsidiary Receives $30 Million Upfront Payment from AstraZeneca

Investor backlash killed AstraZeneca, Bristol Myers tie-up, FT reports

Global Drugmakers Invest Billions to Boost US Presence

$400 Billion Merger Talks Collapse: AstraZeneca and Bristol-Myers Squibb Negotiations Fall Apart

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/AZNH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AZNH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","market":"US","secType":"STK","nameCN":"ASTRAZENECA PLC ADRhedged","latestPrice":53.2774,"timestamp":1787342400000,"preClose":53.2774,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":10000,"shares":30000,"eps":0,"marketStatus":"Halted","change":0,"latestTime":"08-21 16:00:00 EDT","open":53.2774,"high":53.2774,"low":53.2774,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":53.2774,"dividendRate":0.010836,"bidAskSpread":0,"volumeRatio":2.6812474453400963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","floatShares":10000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.6812474453400963,"shares":30000,"dividePrice":0.57729,"high":53.2774,"amplitude":0,"preClose":53.2774,"low":53.2774,"week52Low":44.36,"pbRate":"--","week52High":56.8955,"institutionHeld":0,"latestPrice":53.2774,"eps":0,"divideRate":0.010836,"volume":0,"delay":0,"ttmEps":0,"open":53.2774,"prevYearClose":54.226,"prevWeekClose":53.2774,"prevMonthClose":53.2774,"prevQuarterClose":53.2774,"fiveDayClose":53.2774,"twentyDayClose":53.2774,"sixtyDayClose":53.2774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZNH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"AZNH","amount":0.57729,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2024-12-16","symbol":"AZNH","amount":2.71402,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZNH\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-23","value":2.71402,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.57729,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZNH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZNH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661914172","title":"AstraZeneca Rallies Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2661914172","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661914172?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:08","pubTimestamp":1787328480,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AstraZeneca PLC  advanced 1.26% to GBP122.40 Friday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index  rising 0.64% to 10,816.56.AstraZeneca PLC closed 22.20% below its 52-week high of GBP157.32, which the company reached on February 18th.Trading volume totaled 1.8 million, compared to the 50-day average of 3.3 million.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2417539215.USD","LU2237443465.HKD","LU0432979614.USD","LU0889565916.HKD","IE00B3T34201.USD","LU2089984988.USD","AZNH","LU2237443549.SGD","LU0128525929.USD","LU2237443382.USD","LU1829250122.USD","LU2236285917.USD","LU0320765992.SGD","LU0289739699.SGD","LU2462157665.USD","LU2237443978.SGD","LU2468319806.SGD","BK4568","AZN","LU1267930573.SGD","LU0708994859.HKD","LU2456880835.USD","BK4585","LU0109394709.USD","BK4588","LU2237443622.USD","LU0310800379.SGD","LU2237443895.HKD","LU0058720904.USD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661369612","title":"AstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661369612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661369612?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243448,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca plc (AZN) has launched SELENE 3, a large Phase III trial...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazenecas-selene-3-trial-targets-extra-weight-loss-upside-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazenecas-selene-3-trial-targets-extra-weight-loss-upside-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","IE00B3T34201.USD","BK4211","LU2237443465.HKD","LU2237443895.HKD","LU0320765992.SGD","LU1829250122.USD","BK4585","LU2237443978.SGD","LU2236285917.USD","LU2417539215.USD","LU0708994859.HKD","ISBC","LU2456880835.USD","AZNH","LU2237443382.USD","LU0310800379.SGD","LU0889565916.HKD","LU0109394709.USD","LU0432979614.USD","LU0058720904.USD","BK4007","BK4588","LU2237443549.SGD","LU2237443622.USD","AZN","BK4568","LU2089984988.USD","LU0289739699.SGD","LU1267930573.SGD","LU2462157665.USD","LU0029864427.USD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107150558","title":"Dizhe Pharma Surpasses 500 Million Yuan in First-Half Revenue, Seals Global Exclusive Licensing Pact with AstraZeneca for Sunvozertinib","url":"https://stock-news.laohu8.com/highlight/detail?id=1107150558","media":"Deep News","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107150558?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:04","pubTimestamp":1787231098,"startTime":"0","endTime":"0","summary":"On August 20, Dizhe Pharma unveiled its 2026 interim financial report, disclosing total operating revenue of 523 million yuan for the reporting period, a 47% surge compared to the same period last...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708994859.HKD","LU2456880835.USD","BK4007","AZN","LU2237443382.USD","LU0432979614.USD","IE00B3T34201.USD","LU1267930573.SGD","LU0109394709.USD","LU0889565916.HKD","BK4588","LU2236285917.USD","BK4568","159938","LU2237443622.USD","LU0029864427.USD","BK1515","LU2237443549.SGD","LU2089984988.USD","LU2237443465.HKD","BK1161","LU1829250122.USD","LU2417539215.USD","BK4585","LU2237443978.SGD","LU2237443895.HKD","LU0320765992.SGD","LU0058720904.USD","09939","AZNH","LU0289739699.SGD","LU2462157665.USD","BK1574","LU0310800379.SGD","LU0128525929.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105079363","title":"Third Indication Approved in China for AstraZeneca's Ultomiris","url":"https://stock-news.laohu8.com/highlight/detail?id=1105079363","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105079363?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:54","pubTimestamp":1787216081,"startTime":"0","endTime":"0","summary":"On August 20, the National Medical Products Administration (NMPA) website showed that AstraZeneca PLC (NASDAQ: AZN) has received approval for a new indication for its drug \"Ravulizumab\" in China,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310800379.SGD","LU2237443895.HKD","LU1829250122.USD","LU0289739699.SGD","IE00B3T34201.USD","LU2456880835.USD","BK4585","LU0889565916.HKD","LU0029864427.USD","LU0432979614.USD","BK4007","LU0708994859.HKD","LU0320765992.SGD","LU2237443382.USD","LU1267930573.SGD","BK4588","LU2236285917.USD","LU0058720904.USD","LU0128525929.USD","LU0109394709.USD","LU2237443622.USD","LU2417539215.USD","LU2237443465.HKD","AZNH","IPOS","LU2468319806.SGD","LU2237443978.SGD","LU2089984988.USD","BK4568","AZN","LU2237443549.SGD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660478118","title":"AstraZeneca PLC Stock (AZN) Moved Up by 3.40% on Aug 19: What Signal Does It Send?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660478118","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660478118?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:16","pubTimestamp":1787167000,"startTime":"0","endTime":"0","summary":"• Positive oncology trial results drove AstraZeneca shares upward alongside bullish analyst commentary.\n• Fading merger rumors shifted investor focus back to the company's organic growth.\n• Annual revenue reached $58.74 billion with net profit at $10.22 billion.","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262118853-market-movers-azn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU2462157665.USD","LU0310800379.SGD","LU0289739699.SGD","BK4585","LU0889565916.HKD","LU0058720904.USD","LU0432979614.USD","LU1267930573.SGD","LU2456880835.USD","LU1829250122.USD","LU2468319806.SGD","LU0708994859.HKD","LU0109394709.USD","LU2417539215.USD","LU2237443978.SGD","BK4007","AZN","LU2236285917.USD","LU0029864427.USD","LU2237443895.HKD","LU2237443382.USD","LU2237443465.HKD","LU2237443549.SGD","LU2237443622.USD","AZNH","BK4588","LU2089984988.USD","BK4568","LU0320765992.SGD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660449294","title":"The Key to Pharma M&A: Never Shopping Hungry - Heard on the Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2660449294","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660449294?lang=en_us&edition=fundamental","pubTime":"2026-08-19 17:30","pubTimestamp":1787131800,"startTime":"0","endTime":"0","summary":"Everyone who has walked into a grocery store hungry knows how quickly discipline can evaporate. Everything looks like an immediate necessity.The same psychological trap plays out in Big Pharma boardro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1699723380.USD","LU1066053197.SGD","LU0708994859.HKD","MHIP","LU0211331839.USD","LU0354030511.USD","LU1035773651.USD","BK4550","LU0345770993.USD","LU0210536198.USD","LU0106261372.USD","HRTS","LU2471134796.USD","LU2360032135.SGD","SG9999014914.USD","LU1430594728.SGD","IE00BFSS8Q28.SGD","MRK","LU1061106388.HKD","LU2023251221.USD","LU0965509010.AUD","LU1280957306.USD","LU0306806265.USD","LU1814569148.SGD","LU0985481810.HKD","LU1093756325.SGD","BMY","LU0237698245.USD","LU2602419157.SGD","SG9999015978.USD","SG9999001440.SGD","LU0238689110.USD","LU0943347566.SGD","LU1720051108.HKD","LU2491050154.USD","LU0130517989.USD","LU2361045086.USD","LU2471134952.CNY","LU2264538146.SGD","LU0058720904.USD","IXJ","LU1116320901.HKD","SG9999015952.SGD","LU2552382215.SGD","LU1023059063.AUD","LU0256863902.USD","IE00BFTCPJ56.SGD","LU0466842654.USD","BK4568","LU0882574055.USD","PAWZ","LU0477156953.USD","LU2237443622.USD","IHE","LU2168564495.EUR","LU0820561909.HKD","BK4581","LU2125909593.SGD","SGXZ99366536.SGD","LU1917777945.USD","LU2357305700.SGD","LU0859254822.USD","LU2125154778.USD","SGXZ31699556.SGD","LU1066051811.HKD","LU0109394709.USD","LU1037948897.HKD","RXL","LU1868836757.USD","SG9999014575.USD","LU0094547139.USD","IE0005OL40V9.USD","LU2746668974.SGD","LU0985320562.USD","LU0689472784.USD","LU0432979614.USD","LU2491050071.SGD","IE00BK4W5M84.HKD","LU0316494557.USD","IE00BKPKM429.USD","LU2237443382.USD","LU0786609619.USD","GDOC","LU2750360997.AUD","LU2242652126.USD","LU1989771016.USD","LU2168564222.USD","BK4578","LU0133085943.USD","LU0787776722.HKD","LU0823416689.USD","LU1267930573.SGD","LU0648001328.SGD","LU2756315318.SGD","IE00B1BXHZ80.USD","IE00BKDWB100.SGD","LU2111349929.HKD","LU1571399168.USD","LU0029864427.USD","LU1934455194.USD","LU0708995401.HKD","CANC","GB00BDT5M118.USD","LU0310800379.SGD","LU2237438978.USD","ELIS","LU0266013472.USD","LU0109391861.USD","LU1629891620.HKD","FHLC","LU2125154935.USD","LU0640476718.USD","LU2596442595.SGD","IE000M9KFDE8.USD","LU0158827781.USD","LU0345770308.USD","IE00BJJMRX11.SGD","LU2236285917.USD","SG9999014898.SGD","LU0128525929.USD","LU0868494617.USD","LU1093756168.USD","LU1585245621.USD","LU2211815571.USD","LU0456855351.SGD","LU1941712348.USD","ELIL","IE00B2B36J28.USD","LU0323591593.USD","LU2552382132.HKD","TMED","LU1868837136.USD","LU1974910355.USD","IE00BSNM7G36.USD","LU1037948541.HKD","LU2361044865.SGD","LU2023250330.USD","LU0203345920.USD","LU2265009873.SGD","LU2106854487.HKD","SG9999013999.USD","SG9999001176.SGD","LU2471134879.HKD","LU2756315664.SGD","LU0124676726.USD","LU0098860793.USD","LU0158827948.USD","LU2552382058.USD","SGXZ51526630.SGD","LU0070302665.USD","LU1074936037.SGD","SG9999017495.SGD","LU1941712264.USD","IE00BLSP4452.SGD","LU1923622614.USD","IE00BJJMRY28.SGD","LU1032466523.USD","LU0289739699.SGD","LU0006306889.USD","LU0820561818.USD","LU0061475181.USD","LU0882574139.USD","MEDI","IE0004445015.USD","LU2417539215.USD","LU2089284900.SGD","LU1934455863.HKD","SG9999014542.SGD","LU1232071149.USD","BK4534","LU2271345857.HKD","WDNA","BMED","IE0001KFT4U8.USD","IE00BFXG1179.USD","LU1323610961.USD","LU0823434740.USD","SG9999001176.USD","SG9999015358.SGD","LU1989772923.USD","BK4599","LU0868494708.USD","LU2360106947.USD","NVS","IE00BN29S564.USD","LU2089283258.USD","LU2168564149.EUR","LU0471298777.SGD","LU0942090050.USD","LU0306807586.USD","IE00BJJMRZ35.SGD","LU0114720955.EUR","IE00B4R5TH58.HKD","LU2237443895.HKD","LU1868836914.USD","LU1116320737.USD","LU1551013425.SGD","LU1929549753.HKD","SG9999015986.USD","LLYZ","LU0122379950.USD","SG9999014906.USD","LU0965509283.SGD","JDOC","LU0353189763.USD","BK4588","LU0203347892.USD","LU2746668461.USD","LU2023250504.SGD","LU0321505439.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0965508806.USD","LU0354030438.USD","LU0965509101.SGD","LU0225283273.USD","LU2087625088.SGD","LU0321505868.SGD","LU1670710588.SGD","IE0002141913.USD","LU1261432733.SGD","LU1201861249.SGD","LU2108987350.USD","LU0320765646.SGD","LLII","AGNG","LU0980610538.SGD","LU2468319806.SGD","IE00BJLML261.HKD","LU1551013342.USD","SG9999018865.SGD","SG9999018857.SGD","LU0353189680.USD","MEDX","LU0385154629.USD","LU1720051017.SGD","LU1989772840.SGD","LU1066051225.USD","OZEM","LU2237443978.SGD","LU2896262040.SGD","LU1267930730.SGD","LU1691799644.USD","LU1366192091.USD","LU1162221912.USD","LU0096364046.USD","SGXZ81514606.USD","LU1979441026.SGD","LU1988902786.USD","SG9999015945.SGD","SG9999014559.SGD","LU0672654240.SGD","LU1127390331.HKD","IE0004445239.USD","LU0265550946.USD","LLY","LU0203201768.USD","ILDR","LU2237443465.HKD","SG9999002224.SGD","LU2213496289.HKD","LU1983299246.USD","LLYX","LU2462591350.SGD","SG9999014567.USD","LU1069344957.HKD","LU2324357040.USD","LU0130102774.USD","LU2462157665.USD","SG9999015341.SGD","LU0320765059.SGD","IE00BFSS7M15.SGD","LU0198837287.USD","LU2242646821.SGD","LU2361044949.HKD","AZN","LU2237443549.SGD","IE00BK4W5L77.USD","LU2023250843.SGD","LU0097036916.USD","LU1670711123.USD","LU1712237335.SGD","LU1868837300.USD","LU2491049909.HKD","IE00B3T34201.USD","LU0823434583.USD","LU1064131342.USD","LU1035775433.USD","LU2168563687.JPY","LU2461242641.AUD","IE00B7KXQ091.USD","LU1145028129.USD","LU0234572021.USD","LU2168564065.EUR","LU0225771236.USD","LU1804176565.USD","LU1066051498.USD","LU0256863811.USD","FTXH","IE0009355771.USD","LU1829250122.USD","LU1548497426.USD","LU0320765489.SGD","THNR","IE00BLSP4239.USD","LU0417517546.SGD","LU0689626769.HKD","AZNH","IE00B1XK9C88.USD","CURE","IE00BBT3K403.USD","LU2357627491.SGD","LU0208291251.USD","LU0225284248.USD","LU2089984988.USD","LU2471134523.USD","LU1883839398.USD","LU2433249047.HKD","LU2456880835.USD","BK4516","LU0889565916.HKD","SG9999014880.SGD","IYH","LU0265550359.USD","LU0174119429.USD","PJP","LU2112291526.USD","VHT","LU0320765992.SGD","LU0683600562.USD","BK4559","LU0964807845.USD","LU2028103732.USD","LU1718418525.SGD","BK4585","LU0203202063.USD","LU1069347547.HKD","LU2063271972.USD","SGXZ57979304.SGD","IE00BWXC8680.SGD","LU1623119135.USD","LU0861579265.USD","IE00B4JS1V06.HKD","LU2133065610.SGD","BK4532","LU2750360641.GBP","SG9999002232.USD","LU2125909247.SGD","XLV","LU1670710661.SGD","IE00B775H168.HKD","BK4007","BK4533","IE00BN8TJ469.HKD","LU1868836591.USD","LU0267386448.USD","LU0079474960.USD","LU1934455277.USD","LU0820562030.AUD","LU1291159041.SGD","TRUH","LU1670711040.USD","PPH","LU0471298694.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492411","title":"BMO starts Exelixis at Market Perform into patent cliff","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492411?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:30","pubTimestamp":1787085023,"startTime":"0","endTime":"0","summary":"BMO Capital initiated coverage of Exelixis (EXEL) with a Market Perform rating and $54 price target Exelixis is anchored by cabozantinib, a “durabl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bmo-starts-exelixis-at-market-perform-into-patent-cliff-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bmo-starts-exelixis-at-market-perform-into-patent-cliff-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","BK4207","XPH","TMED","FBT","APXH","LU2272731865.HKD","USRD","MEDX","TRUH","PPH","RXL","EXEL","BME","LU2473716301.USD","LU2272731600.USD","RXD","LU2322448957.HKD","AZNH","BMO","MEDI","FHLC","LU2322448791.USD","SYNB","LU1992135472.HKD","JDOC","BK4585","FTXH","IYH","IBB","IHE","RSPH","BK4532","LU1992135399.USD","GSKH","IE00B5TLWC47.USD","PJP","PBPH","BBH","FXH","PTH","LU2272731782.SGD","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660691496","title":"AstraZeneca Rises Tuesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2660691496","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660691496?lang=en_us&edition=fundamental","pubTime":"2026-08-19 00:07","pubTimestamp":1787069220,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.AstraZeneca PLC  shares rallied 2.13% to GBP118.06 Tuesday, on what proved to be an all-around favorabl","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU2462157665.USD","LU0310800379.SGD","LU0289739699.SGD","BK4585","LU0889565916.HKD","LU0058720904.USD","LU0432979614.USD","LU1267930573.SGD","LU2456880835.USD","LU1829250122.USD","LU2468319806.SGD","LU0708994859.HKD","LU0109394709.USD","LU2417539215.USD","LU2237443978.SGD","BK4007","AZN","LU2236285917.USD","LU0029864427.USD","LU2237443895.HKD","LU2237443382.USD","LU2237443465.HKD","LU2237443549.SGD","LU2237443622.USD","AZNH","BK4588","LU2089984988.USD","BK4568","LU0320765992.SGD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660959154","title":"European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2660959154","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660959154?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:13","pubTimestamp":1787066007,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower in late Tuesday morning trading, declining 0.50% to 1,960.50 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by software firm SAP  and pharmaceutical company Sanofi , which increased 1.7% and 1.6% respectively. They were followed by healthcare tech company Royal Philips  and biopharmaceutical company DBV Technologies , which were up 1.5% and 1.3% respectively.The decliners from continental Europe were led by telecommunications company Nokia  and biopharmaceutical company Cellectis , which lost 3.8% and 2.9% respectively. They were followed by biotech firm Evaxion  and furniture maker Natuzzi , which dropped 1.6% and 1.5% respectively.The gainers from the UK were led by software firm Endava  and communications company WPP , which advanced 4.1% and 2.6% respectively. They were followed by pharmaceutical company AstraZeneca  and biotech company Trinity Biotech , which ro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2468319806.SGD","LU2089984988.USD","BK4007","BK4521","LU0320765992.SGD","BK4588","BK4009","LU2462157665.USD","SAP","PHG","LU2237443549.SGD","MREO","BK4547","LU0432979614.USD","TRIB","DAVA","DBVT","BK4023","NTZ","BK4134","LU0058720904.USD","LU2237443978.SGD","BK4568","BCS","NOK","EPV","BK4528","SNY","SLN","EVAX","BK4117","LU0006061336.USD","AKTX","LU0708994859.HKD","LU0128525929.USD","BK4505","AZN","DAVA.AU","BK4139","LU0648005311.SGD","LU2237443895.HKD","IEUR","LU0029864427.USD","CLLS","WPP","WPP.AU","AZNH","AFG","LNOK","LU2237443382.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147203765","title":"AstraZeneca's Biologic Therapy Receives Dual Indication Approval for Launch in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1147203765","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147203765?lang=en_us&edition=fundamental","pubTime":"2026-08-18 15:48","pubTimestamp":1787039300,"startTime":"0","endTime":"0","summary":"On August 17, AstraZeneca PLC (AZN.US) announced the official market launch of Tezepelumab injection in China. This biologic is designed to address severe asthma, overcoming limitations related to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0432979614.USD","LU0310800379.SGD","LU2462157665.USD","LU0128525929.USD","LU1829250122.USD","LU0289739699.SGD","IE00B3T34201.USD","BK4007","LU2236285917.USD","LU0320765992.SGD","LU2237443382.USD","LU2237443465.HKD","LU1267930573.SGD","LU2456880835.USD","BK4585","LU2237443978.SGD","LU2468319806.SGD","BK4568","LU0889565916.HKD","LU2417539215.USD","BK4588","LU2237443622.USD","LU2237443549.SGD","LU0708994859.HKD","LU2237443895.HKD","IPOS","LU0058720904.USD","LU0029864427.USD","AZN","AZNH","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660438048","title":"AstraZeneca to discontinue eVOLVE-Lung02 Phase III trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2660438048","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660438048?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:35","pubTimestamp":1786973714,"startTime":"0","endTime":"0","summary":"AstraZeneca (AZN) announced that it is discontinuing the eVOLVE-Lung02 Phase III trial evaluating volrustomig in combination with chemotherapy as a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-to-discontinue-evolve-lung02-phase-iii-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-to-discontinue-evolve-lung02-phase-iii-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443895.HKD","LU0289739699.SGD","LU2468319806.SGD","LU2237443465.HKD","LU2237443978.SGD","III","BK4134","LU0320765992.SGD","LU0889565916.HKD","LU2456880835.USD","LU2089984988.USD","LU0432979614.USD","LU0029864427.USD","BK4585","LU1267930573.SGD","LU2237443549.SGD","LU0058720904.USD","BK4568","LU2462157665.USD","AZN","LU0128525929.USD","LU2237443382.USD","BK4588","AZNH","LU0310800379.SGD","LU2236285917.USD","LU1829250122.USD","LU2237443622.USD","IE00B3T34201.USD","BK4007","LU0109394709.USD","LU2417539215.USD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132478153","title":"Breakthrough: AstraZeneca and Daiichi Sankyo's ADC Shows Strong Efficacy in First-Line Lung Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1132478153","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132478153?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:48","pubTimestamp":1786970902,"startTime":"0","endTime":"0","summary":"On August 17, AstraZeneca PLC and Daiichi Sankyo jointly announced that the Phase III DESTINY-Lung04 trial evaluating Enhertu (trastuzumab deruxtecan) as a monotherapy in the first-line treatment of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","LU2237443895.HKD","BK4080","IE00B3T34201.USD","LU2237443549.SGD","BK4568","LU2237443382.USD","LU1267930573.SGD","LU2236285917.USD","LU2237443978.SGD","BK4134","NETL","LU2468319806.SGD","AZNH","LU2417539215.USD","LU0320765992.SGD","LU2089984988.USD","LU0058720904.USD","BK4007","LU0109394709.USD","LU2456880835.USD","III","LU0708994859.HKD","LU0029864427.USD","AZN","LU2462157665.USD","LU0128525929.USD","LU0289739699.SGD","LU0889565916.HKD","LU0432979614.USD","LU0310800379.SGD","ADC","BK4585","BK4588","LU2237443622.USD","BK4231","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660703482","title":"AstraZeneca (AZN) Gets a Buy from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660703482","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660703482?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:55","pubTimestamp":1786967719,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Richard Vosser maintained a Buy rating on AstraZeneca today and set a price target of £160.00. According to TipRanks, Vosser is...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-j-p-morgan-blurbs-news-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-j-p-morgan-blurbs-news-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443465.HKD","LU1732800096.USD","LU2236285917.USD","LU0320765992.SGD","LU0528227936.USD","LU0795875169.SGD","LU2456880835.USD","LU0971096721.USD","LU0557290698.USD","LU2237443895.HKD","LU2417539215.USD","KBWB","BK4127","LU0320765646.SGD","LU2357305700.SGD","LU0058720904.USD","LU2237443549.SGD","LU2237443382.USD","LU2028103732.USD","LU1074936037.SGD","LU2133065610.SGD","BK4585","LU0390134368.USD","AZN","BK4504","BK4588","LU0158827781.USD","LU0128525929.USD","IE00BZ1G4Q59.USD","IAI","LU0432979614.USD","LU0029864427.USD","BK4007","BK4568","LU2089984988.USD","LU1244550494.USD","LU1064131342.USD","LU0267386448.USD","LU0708994859.HKD","LU0210528500.USD","LU0098860793.USD","LU0795875086.SGD","LU2089284900.SGD","LU0106261372.USD","LU2089283258.USD","LU2237443622.USD","AZNH","LU0109394709.USD","IE00B3T34201.USD","LU0158827948.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660000731","title":"AstraZeneca Discontinues Phase 3 Lung Cancer Trial for Volrustomig Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2660000731","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660000731?lang=en_us&edition=fundamental","pubTime":"2026-08-17 15:35","pubTimestamp":1786952124,"startTime":"0","endTime":"0","summary":"AstraZeneca  is stopping a phase 3 trial evaluating volrustomig in combination with chemotherapy for patients with metastatic non-small cell lung cancer, the company said Monday.An independent data monitoring committee recommended halting the trial after finding the combination was unlikely to meet its primary survival goals, the company said.The treatment showed a safety profile consistent with existing data without any new safety signals, AstraZeneca said.The other phase 3 studies testing volrustomig in cervical cancer, head and neck cancer, and mesothelioma will proceed as planned, it said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","LU0058720904.USD","LU0310800379.SGD","BK4585","AZNH","LU2089984988.USD","LU2237443622.USD","LU0320765992.SGD","LU2237443382.USD","LU0708994859.HKD","LU0109394709.USD","LU2468319806.SGD","BK4007","LU0128525929.USD","LU2236285917.USD","LU0289739699.SGD","LU2417539215.USD","LU0432979614.USD","LU2237443465.HKD","IE00B3T34201.USD","LU1829250122.USD","LU2237443895.HKD","LU2456880835.USD","LU2462157665.USD","LU1267930573.SGD","LU2237443978.SGD","AZN","LU0029864427.USD","LU2237443549.SGD","BK4588","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166055","title":"AstraZeneca’s STEP Asthma Trial Completion: What It Could Mean for AZN Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166055","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166055?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:30","pubTimestamp":1786638610,"startTime":"0","endTime":"0","summary":"AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The STEP Phase 3b study from AstraZeneca looks at whether patients with se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazenecas-step-asthma-trial-completion-what-it-could-mean-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazenecas-step-asthma-trial-completion-what-it-could-mean-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU0432979614.USD","LU0310800379.SGD","LU2462157665.USD","LU0128525929.USD","LU1829250122.USD","LU0289739699.SGD","IE00B3T34201.USD","ISBC","LU2236285917.USD","LU0320765992.SGD","STEP","BK4211","LU2237443382.USD","LU2237443465.HKD","LU1267930573.SGD","LU2456880835.USD","BK4585","LU2237443978.SGD","LU2468319806.SGD","BK4568","LU0889565916.HKD","LU2417539215.USD","BK4588","LU2237443622.USD","LU2237443549.SGD","LU0708994859.HKD","LU2237443895.HKD","LU0058720904.USD","LU0029864427.USD","BK4135","BK4007","AZNH","LU2089984988.USD","AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121610795","title":"New Approval in China for Enhertu, a Key Antibody-Drug Conjugate from Daiichi Sankyo and AstraZeneca","url":"https://stock-news.laohu8.com/highlight/detail?id=1121610795","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121610795?lang=en_us&edition=fundamental","pubTime":"2026-08-13 07:28","pubTimestamp":1786577294,"startTime":"0","endTime":"0","summary":"A new indication for the antibody-drug conjugate (ADC) Enhertu, developed in collaboration between Daiichi Sankyo and AstraZeneca PLC (AZN.US), has secured approval for marketing in China as of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU1829250122.USD","LU2237443978.SGD","LU0128525929.USD","LU0109394709.USD","LU2237443549.SGD","ADC","LU0889565916.HKD","LU2236285917.USD","NETL","IE00B3T34201.USD","LU2237443622.USD","LU0432979614.USD","LU0708994859.HKD","BK4231","LU0029864427.USD","BK4080","IPOS","BK4007","AZNH","LU0289739699.SGD","LU0320765992.SGD","AZN","LU2237443465.HKD","LU2468319806.SGD","LU2417539215.USD","BK4585","LU2456880835.USD","LU2089984988.USD","LU0310800379.SGD","LU1267930573.SGD","BK4568","LU2237443382.USD","LU2237443895.HKD","BK4588","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101412793","title":"Cspc Innovation's Subsidiary Receives $30 Million Upfront Payment from AstraZeneca","url":"https://stock-news.laohu8.com/highlight/detail?id=1101412793","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101412793?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:56","pubTimestamp":1786532201,"startTime":"0","endTime":"0","summary":"Cspc Innovation Pharmaceutical Co., Ltd. (300765.SZ) announced that on July 1, 2026, its controlling subsidiary, Jushi Biologics, signed a Collaboration, Option, and License Agreement with...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","AZNH","LU0289739699.SGD","LU2462157665.USD","LU2468319806.SGD","LU0029864427.USD","LU0320765992.SGD","LU2456880835.USD","LU0109394709.USD","LU2417539215.USD","LU2237443549.SGD","LU0708994859.HKD","BK4585","LU2236285917.USD","BK4588","300765","LU0058720904.USD","LU0432979614.USD","BK4568","LU2237443622.USD","IE00B3T34201.USD","LU2237443465.HKD","LU0128525929.USD","LU0310800379.SGD","LU2237443978.SGD","LU2089984988.USD","LU0889565916.HKD","BK0226","LU1829250122.USD","LU2237443382.USD","LU2237443895.HKD","LU1267930573.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658571948","title":"Investor backlash killed AstraZeneca, Bristol Myers tie-up, FT reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2658571948","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658571948?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:55","pubTimestamp":1786478122,"startTime":"0","endTime":"0","summary":"AstraZeneca (AZN) CEO Pascal Soriot had been quietly pursuing a transformative deal and held serious talks with Bristol Myers (BMY) over a potentia...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/investor-backlash-killed-astrazeneca-bristol-myers-tie-up-ft-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/investor-backlash-killed-astrazeneca-bristol-myers-tie-up-ft-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0321505439.SGD","LU2596442595.SGD","LU2125154778.USD","LU0432979614.USD","IE00B2B36J28.USD","LU2462157665.USD","LU0237698245.USD","LU0128525929.USD","LU0306807586.USD","LU1261432733.SGD","LU1883839398.USD","LU1868836591.USD","FTXH","LU0310800379.SGD","LU2125154935.USD","BK4007","LU0029864427.USD","LU1989771016.USD","AZNH","LU1430594728.SGD","BK4581","IE00BFXG1179.USD","LU1571399168.USD","IHE","LU1585245621.USD","IE0002141913.USD","LU1829250122.USD","BK4126","BMY","LU0321505868.SGD","LU1868837136.USD","LU1267930573.SGD","LU1323610961.USD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","LU2456880835.USD","LU0889565916.HKD","BK4532","AZN","MYE","LU2468319806.SGD","LU2237443549.SGD","IE00B3T34201.USD","LU0882574055.USD","LU0708994859.HKD","LU1983299246.USD","LU1670711040.USD","LU1868836914.USD","LU2089984988.USD","LU2237443382.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911015","title":"Global Drugmakers Invest Billions to Boost US Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911015?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:57","pubTimestamp":1786463857,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers invest billions to boost US presenceAug 11 (Reuters)-Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N44815K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","LU0053666078.USD","LU0395794307.EUR","NVO","PJP","LU2129689514.USD","IE00BKPKM429.USD","LU0689472784.USD","LU0553294199.USD","LU0070217475.USD","LU1121112475.USD","LU1043141396.HKD","LU0320765489.SGD","LU2237443382.USD","LU0323591593.USD","LU0058720904.USD","LU2552382058.USD","NVOX","LU2471134879.HKD","LU1720051108.HKD","SG9999015978.USD","SG9999014542.SGD","LU0266013472.USD","AGNG","LU0061475181.USD","LU0466842654.USD","LU1670710661.SGD","LU0133085943.USD","LU0158827948.USD","LU1989772840.SGD","IE000WAW04H5.SGD","LU0985481810.HKD","AZNH","LU2087625088.SGD","LU1988902786.USD","LU1093756168.USD","LU2133065610.SGD","LU0310800379.SGD","VHT","SGXZ80539844.SGD","SGXZ99366536.SGD","IE00B19Z9Z06.USD","LU0385154629.USD","LU2111349929.HKD","LU1221951046.USD","IE000BZT7R73.USD","LU1003077747.HKD","LU2089984988.USD","SG9999015952.SGD","LU2487616109.SGD","LU0820562030.AUD","LU1064131342.USD","LU2237443549.SGD","LU1066051498.USD","LU1941712264.USD","BK4599","PFE","LU2265009873.SGD","LU2237443622.USD","LU0289739343.SGD","IE00B3T34201.USD","LU0006306889.USD","SG9999014906.USD","PBE","LU0868494708.USD","LU2271345857.HKD","LU2125909593.SGD","IE00BGHQF631.EUR","LU1267930730.SGD","LU1291159041.SGD","LU0471298777.SGD","LU2213496289.HKD","LLYZ","LU0354030511.USD","IE00BN29S564.USD","LU2750360641.GBP","LU0345769631.USD","LU1674673428.USD","LU1814569148.SGD","LU1670628061.USD","LU0158827781.USD","LU0545562505.USD","LU0889565916.HKD","BK4532","SG9999015986.USD","LU2023250843.SGD","IE00B1XK9C88.USD","LU0795875169.SGD","LU2106854487.HKD","LU0545039389.USD","AZN","LU0345770993.USD","LU2430703251.USD","LU1035773651.USD","BK4588","LU2461242641.AUD","LU0203347892.USD","LU1883839398.USD","CSL.AU","SG9999014567.USD","IE00B894F039.SGD","LU1732799900.SGD","LU1037948897.HKD","LU0823416689.USD","LU1934455194.USD","LU1145028129.USD","IYH","JDOC","GDOC","HRTS","LU0477156953.USD","LU1894683264.USD","IE00BK4W5M84.HKD","LU0122379950.USD","BBH","LU2237438978.USD","SG9999018865.SGD","LU0345769128.USD","LU2456880835.USD","LU1267930573.SGD","LU2596442595.SGD","LU0256863811.USD","LU0097036916.USD","LU1032955483.USD","LU0109394709.USD","LU1267930813.SGD","LU1571399168.USD","LU0661504455.SGD","LU2756315664.SGD","LU2242652126.USD","BK4583","LU0426412945.USD","GSKH","LU1868836914.USD","LU1023059063.AUD","LU0708995401.HKD","LU1069344957.HKD","LU2168563687.JPY","LU2505996509.AUD","IE00BFTCPJ56.SGD","LU1670711123.USD","LU1989772923.USD","LU0203202063.USD","LU1989771016.USD","BK4516","LU0726765562.USD","IE0004445015.USD","LU0225284248.USD","SG9999015341.SGD","LU1670711040.USD","BK4534","SG9999014575.USD","LU0128525929.USD","NVOH","GSK.UK","LU1979441026.SGD","IE0005OL40V9.USD","IE00BVYPNV92.GBP","LU1718418525.SGD","LU0964807845.USD","NVS","CANC","LU0426417589.USD","LU0029864427.USD","LU0792757196.USD","IE0001KFT4U8.USD","LU0234572021.USD","LU1261432733.SGD","BK4566","BK4139","WDNA","LU1732800096.USD","LU0640476718.USD","LU1868836591.USD","LU0472753341.HKD","LU1244550494.USD","LU0306806265.USD","LU0106261372.USD","LU0868494617.USD","LU2028103732.USD","LLY","BK7501","IE00B4JS1V06.HKD","SG9999001176.SGD","TRUH","IE00BJJMRY28.SGD","IE00B19Z9P08.USD","LU2347655073.USD","LU0708994859.HKD","SG9999015358.SGD","FHLC","IE00BJJMRX11.SGD","LU2471134523.USD","BK4578","LU0210536198.USD","LU2063271972.USD","IE0000B7K699.USD","ABBV","LU0098860793.USD","LU1934455277.USD","BK4504","LU2896262040.SGD","SG9999003800.SGD","LU0072461881.USD","BK4550","LU2168564495.EUR","LLYX","LU0965509101.SGD","LU1935042991.SGD","SGXZ51526630.SGD","IHE","LU2168564222.USD","LU1244550221.USD","LLII","LU2357627491.SGD","LU0889566641.SGD","LU1670710588.SGD","LU2264538146.SGD","LU2491049909.HKD","LU0208291251.USD","LU2347655156.SGD","LU0310799852.SGD","LU1548497426.USD","IE00BJT1NW94.SGD","IE00B42XCP33.USD","LU0985320562.USD","LU1043141123.HKD","GILD","IE00BDGV0183.EUR","LU1116320737.USD","LU1934455863.HKD","SG9999002224.SGD","RHHBY","IE000MB6IJN5.SGD","LU0265550359.USD","LU1035775433.USD","MHIP","LU1923622614.USD","LU0070302665.USD","LU1506573853.SGD","LU1914381329.SGD","IE00BKDWB100.SGD","LU2471134796.USD","LU0511384066.AUD","SNY","IXJ","LU0965508806.USD","LU0109391861.USD","LU1839511570.USD","IE00BLSP4239.USD","LU1228905037.USD","LU0096364046.USD","LU0267386448.USD","IE0004445239.USD","LU1430594728.SGD","SG9999014914.USD","MEDX","LU2746668461.USD","IE00BJJMRZ35.SGD","PAWZ","GSK","LU1868837136.USD","IE00BSNM7G36.USD","FTXH","IE00B19Z3581.USD","ELIS","IE00B7KXQ091.USD","IE000F7OJYX1.SGD","LU2552382215.SGD","LU2129689605.HKD","BK4585","LU0154236417.USD","LU0683600562.USD","IBBQ","LU2417539215.USD","LU0265550946.USD","LU1829250122.USD","SGXZ57979304.SGD","LU0174119429.USD","IE00B7SZLL34.SGD","BK4592","LU0225283273.USD","SG9999017495.SGD","LU1037948541.HKD","LU2108987350.USD","IE000M9KFDE8.USD","LU2592432038.USD","IE0002141913.USD","LU1551013342.USD","SG9999002232.USD","LU2023250504.SGD","LU0882574139.USD","IE0034235303.USD","BIIB","LU0354030438.USD","LU1778281490.HKD","LU1894683348.USD","LU2324357040.USD","04332","JNJ","LU1585245621.USD","LU0203201768.USD","SG9999015945.SGD","IE00B1BXHZ80.USD","LU0320765059.SGD","LU1127390331.HKD","LU1974910355.USD","LU0114720955.EUR","LU1623119135.USD","SG9999014559.SGD","LU0882574055.USD","LU1674673691.USD","LU0225771236.USD","BMY","LU1712237335.SGD","LU0069063385.USD","LU0198837287.USD","LU0211328371.USD","IE00BK4W5L77.USD","LU2129689431.USD","LU0256863902.USD","LU1366192091.USD","LU2430703178.SGD","BK4007","LU0320765646.SGD","LU0965509010.AUD","LU2089283258.USD","LU0211331839.USD","IE00BFSS7M15.SGD","MRK","LU0237698245.USD","LU1162221912.USD","LU1093756325.SGD","IE00B3PB1722.GBP","LU2211815571.USD","SG9999001176.USD","LU1983299246.USD","IE00BFXG1179.USD","LU0823434583.USD","LU2237443465.HKD","LU2361044949.HKD","XLV","LU1228905540.USD","LU0289961442.SGD","LU2361045086.USD","LU2357305700.SGD","LU2125154935.USD","LU0456855351.SGD","LU1496350171.SGD","OZEM","LU0820561818.USD","LU0238689110.USD","LU0321505439.SGD","LU2505996681.GBP","LU0306807586.USD","LU0211327993.USD","LU0943347566.SGD","LU2433249047.HKD","LU1221951129.SGD","RXL","LU0057025933.USD","LU1929549753.HKD","LU0823434740.USD","SG9999018857.SGD","LU0353189680.USD","LU2491050154.USD","BK4559","LU0648001328.SGD","LU2125154778.USD","IE0002270589.USD","IE00BWXC8680.SGD","LU2125909247.SGD","LU0320765992.SGD","LU0820561909.HKD","BK4568","LU0787776722.HKD","IE00BFSS8Q28.SGD","LU2112291526.USD","IE00BN8TJ469.HKD","BIB","LU0124676726.USD","LU0689626769.HKD","LU2360032135.SGD","LU1804176565.USD","LU0417517546.SGD","LU2462591350.SGD","SGXZ31699556.SGD","LU1196500208.SGD","LU2471134952.CNY","LU1699723380.USD","IE00BLSP4452.SGD","LU0432979614.USD","LU0094547139.USD","BMED","LU1496350502.SGD","LU2236285917.USD","BK7067","LU2361044865.SGD","LU0912757837.SGD","LU1061106388.HKD","SG9999001440.SGD","LU2237443895.HKD","IE00BVYPNW00.USD","LU2360106947.USD","GLAM","LU0942090050.USD","LU1074936037.SGD","LU0321505868.SGD","LU2468319806.SGD","IE00BBT3K403.USD","IE00B775H168.HKD","LU2430703095.HKD","ELIL","LU1280957306.USD","SG9999013999.USD","LU1059921491.USD","IE00B4R5TH58.HKD","TBXU","THNR","IE000SO60NU8.SGD","LU0234570918.USD","LU2087621335.USD","ILDR","LU2023251221.USD","IE00BZ1G4Q59.USD","LU1323610961.USD","LU0130102774.USD","GB00BDT5M118.USD","LU2242646821.SGD","03165","LU1868837300.USD","LU2491050071.SGD","LU1057294990.SGD","LU0162691827.USD","LU2746668974.SGD","LU1629891620.HKD","SG9999014880.SGD","LU1232071149.USD","LU0994945656.USD","LU2403377893.USD","LU1941712348.USD","LU1720051017.SGD","IE00B2B36J28.USD","BK4581","LU2462157665.USD","LU0471298694.HKD","LU2750360997.AUD","LU1066053197.SGD","LU0949170772.SGD","LU2089284900.SGD","LU2756315318.SGD","BK7511","LU0965509283.SGD","LU1244550577.SGD","SG9999011175.SGD","LU0861579265.USD","MEDI","BK7508","BK4533","LU1069347547.HKD","LU2023250330.USD","LU0130517989.USD","IE00B19Z3B42.SGD","LU0353189763.USD","LU1201861249.SGD","SG9999014898.SGD","LU0672654240.SGD","LU0170899867.USD","LU2168564149.EUR","LU1066051225.USD","LU2602419157.SGD","TMED","LU0316494557.USD","IBB","LU1551013425.SGD","IE00BKVL7J92.USD","PPH","LU1116320901.HKD","LU2168564065.EUR","LU0786609619.USD","IE00BJLML261.HKD","LU0210528500.USD","IE0009355771.USD","LU1267930490.SGD","LU0345770308.USD","LU1066051811.HKD","LU2552382132.HKD","LU1868836757.USD","LU0980610538.SGD","LU1917777945.USD","LU0738911758.USD","LU0289739699.SGD","LU0859254822.USD","LU0795875086.SGD","AMGN","LU1670627923.USD","LU0203345920.USD","SGXZ81514606.USD","LU2237443978.SGD","LU1032466523.USD","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125292855","title":"$400 Billion Merger Talks Collapse: AstraZeneca and Bristol-Myers Squibb Negotiations Fall Apart","url":"https://stock-news.laohu8.com/highlight/detail?id=1125292855","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125292855?lang=en_us&edition=fundamental","pubTime":"2026-08-11 14:50","pubTimestamp":1786431043,"startTime":"0","endTime":"0","summary":"AstraZeneca PLC CEO Pascal Soriot had repeatedly assured investors the company could reach its $80 billion revenue target by the start of the next decade without relying on a major acquisition....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310800379.SGD","IE00B3T34201.USD","LU2237443465.HKD","LU1585245621.USD","BK4568","MYLD","LU0320765992.SGD","LU1670711040.USD","LU0708994859.HKD","LU2089984988.USD","LU0882574055.USD","LU0321505868.SGD","LU2360032135.SGD","KCE","IE00BSNM7G36.USD","LU1093756168.USD","LU0114720955.EUR","LU0321505439.SGD","LU2242652126.USD","LU1323610961.USD","LU1868836914.USD","LU1983299246.USD","BK4534","LU0109394709.USD","LU2125154935.USD","LU0029864427.USD","LU1883839398.USD","LU1261432733.SGD","LU2237443382.USD","LU1670710661.SGD","LU1267930573.SGD","BK4581","CALF","IE00BFTCPJ56.SGD","LU0061475181.USD","LU2462157665.USD","LU0267386448.USD","LU1670711123.USD","LU1989771016.USD","LU0225771236.USD","LU1868837136.USD","LU1868836757.USD","LU0289739699.SGD","BK4559","LU1868836591.USD","LU0128525929.USD","LU2237443622.USD","LU2237443978.SGD","IE00BJT1NW94.SGD","LU2236285917.USD","LU1670710588.SGD","LU1032466523.USD","IE00BFXG1179.USD","BK4588","LU1868837300.USD","IHE","LU1093756325.SGD","LU2237443549.SGD","LU0306807586.USD","BK4532","LU0096364046.USD","LU2468319806.SGD","BMY","BK4585","LU1571399168.USD","LU2133065610.SGD","LU1291159041.SGD","LU0432979614.USD","LU2417539215.USD","LU0985481810.HKD","LU0456855351.SGD","LU2596442595.SGD","AZNH","LU2242646821.SGD","IE00B2B36J28.USD","BK4007","LU1430594728.SGD","IE00BJJMRZ35.SGD","LU1829250122.USD","IE0009355771.USD","LU0058720904.USD","AZN","FTXH","LU0225284248.USD","LU2125154778.USD","LU0237698245.USD","IE0002141913.USD","LU0306806265.USD","LU0889565916.HKD","LU1074936037.SGD","LU2237443895.HKD","LU2456880835.USD","LU1718418525.SGD","XMMO","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}